EVENT DETAILS
Thursday, May 10, 2018
Hilton Boston/Woburn
2 Forbes Road,
Woburn, MA 01810
Time
8:00 AM - 5:00 PM
Total Credits
7 Contact Hour(s)
Target Audience
Pharmacist , Pharmacy Technician
Cost
$129.00
Registration closes on 5/9/2018 at 11:00 PM
 

Registration will be held from 8:00 am - 8:30 am. Continental breakfast will be served during this time.

A plated lunch will be served from 12:00 pm - 1:00 pm.

Refreshments will be served during the afternoon programs.

 

AGENDA

Scheduled CE Activities Thursday, May 10, 2018
  
Major advances have been made in managing HCV infection in recent years with the advent of Direct Acting Antiviral (DAA) therapy. This presentation will review recent changes to AASLD HCV Management Guidelines and highlight the role of new pangenotypic regimens for HCV. In addition, the role of the pharmacist will be discussed as it relates to drug selection, prevention of drug drug interactions and cost containment.
 
 
Pharmacist Learning Objectives
  • List and review recent changes to AASLD HCV Guidelines
  • Describe the role pangenotypicia regimens in managing HCV
  • Compare and contrast the role of HCV management in HCV monoinfected and HIV/HCV co-infected patients
  • List the common drug interactions likely to occur with HCV medication
  • Provide reputable resources for managing HIV and HCV co-infection
Pharmacy Technician Learning Objectives
  • Describe the role of ancillary staff and technicians in securing HCV medications
  • Provide three interventions that technicians can provide to assist patients in maintaining adherence to HCV regimens
 
Faculty
John FaragonPharmD, BCPS, AAHIVP
Regional Pharmacy Director, North East Caribbean AIDS Education and Training Center
 
ACPE UAN
0280-9999-18-017-L01-P (Knowledge-Based)
0280-9999-18-017-L01-T (Knowledge-Based)
 
Credits
1.5
 
Handouts
 
Supported By
AIDS Education & Training Center
 
Healthcare teams boast unprecedented resources and tools for reduction in medication error. Despite staggering technological advances, errors continue. In fact, new opportunities for error have emerged with some of the very tools intended to eliminate systematic errors. Using established psychological principles, human engineering factors are examined and extrapolated to the unique challenges of the contemporary pharmacy setting. Recurring problematic areas in pharmacy practice will be extensively examined within the framework of an effective Continuous Quality Improvement (CQI) Plan and appropriate use of the Root Cause Analysis (RCA) method in identifying, reporting, and evaluating sentinel events.
 
 
Pharmacist Learning Objectives
  • Describe the medication safety challenges brought on by computerized physician order entry
  • Identify tools and models for error reduction and patient safety advocacy
  • Describe the national trends in pharmacy technician education and training standards
  • Identify error-prone abbreviations from ISMP’s “Do Not Use” list
Pharmacy Technician Learning Objectives
  • Describe the medication safety challenges brought on by computerized physician order entry
  • Identify tools and models for error reduction and patient safety advocacy
  • Describe the national trends in pharmacy technician education and training standards
  • Identify error-prone abbreviations from ISMP’s “Do Not Use” list
 
Faculty
Kevin HopeRPh
Clinical Education Specialist and Continuing Education Administrator, PharmCon, Inc.; Advisory Board Member, Paradigm Education Solutions; Nuclear Pharmacist, Triad Isotopes
 
ACPE UAN
0280-0000-18-015-L05-P (Knowledge-Based)
0280-0000-18-015-L05-T (Knowledge-Based)
 
Credits
1.5
 
Handouts
 
Supported By
American Health Resources, LLC.
 
Patients with diabetes are also much more likely to suffer from cardiovascular disease than those without diabetes. In fact, cardiovascular disease is the leading cause of death associated with diabetes – certainly a medical double jeopardy. The American Diabetes Association’s (ADA) recently published the 2017 Standards of Medical Care in Diabetes and included new recommendations on treating both diabetes and cardiovascular disease. Pharmacists are often the medical professional that patients reach out to for guidance and explanation on new pharmaco-therapy and individualized treatment. This program will review the ADA’s latest update to the Standards of Medical Care in Diabetes, review recent outcomes trials of antihyperglycemic therapies in patients with type 2 diabetes (T2D) and outline evidence based treatment strategies to mitigate the risk of cardiovascular disease in patients with T2D.
 
 
Pharmacist Learning Objectives
  • Summarize the ADA and AACE guidelines with respect to efficacy and safety particularly when analyzing cardiovascular and renal outcomes.
  • Recognize evidence-based treatment options that optimize glycemic, cardiovascular, and renal outcomes in patients with type 2 diabetes.
  • Communicate the potential cardiovascular benefits and risk of various treatment approaches for diabetes to patients and members of the healthcare team.
Pharmacy Technician Learning Objectives
  • Identify the diabetes medications that are recommended by the ADA and the AACE guidelines in people with cardiovascular and renal risks.
  • Recognize the drug therapies that show evidence of benefit in improving blood sugars and decreasing risk of cardiovascular and renal events.
  • Identify guidelines that are recommended by the ADA and AACE for CV risk reduction and the others in this class.
 
Faculty
Jennifer GoldmanPharmD, CDE, BC-ADM, FCCP
Professor of Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences
 
ACPE UAN
0280-0000-18-018-L01-P (Knowledge-Based)
0280-0000-18-018-L01-T (Knowledge-Based)
 
Credits
2
 
Handouts
 
Supported By
Novo Nordisk
 
The presentation on the Pharmacy Substance Use Disorder Program (PSUD) will review and summarize the Opioid Crisis and its impact on substance use disorder in the pharmacy profession.; It will present the new Pharmacy Substance Use Disorder programs (PSUD) available for Pharmacist, Pharmacy Interns and Pharmacy Technicians in the Commonwealth of Massachusetts at the Board of Pharmacy.
 
 
Pharmacist Learning Objectives
  • Recognize the impact of Substance Use Disorder (SUD) in the Pharmacy Community
  • Explain the role of the Massachusetts Pharmacists Substance Use Disorder Program in treatment and recovery for pharmacists, interns and technicians
Pharmacy Technician Learning Objectives
  • Recognize the impact of Substance Use Disorder (SUD) in the Pharmacy Community
  • Explain the role of the Massachusetts Pharmacists Substance Use Disorder Program in treatment and recovery for pharmacists, interns and technicians
 
Faculty
Edmond J. TaglieriMSM, RPh, NHA
PSUD Supervisor for Massachusetts Board of Pharmacy
 
ACPE UAN
0280-0000-18-024-L03-P (Knowledge-Based)
0280-0000-18-024-L03-T (Knowledge-Based)
 
Credits
1
 
Handouts
 
Supported By
American Health Resources, LLC.
 
4:00 PM - 5:00 PM
The differences and enforceability of the new and proposed regulations will be presented as well as a summary of new Pharmacy Board policies. During an inspection, pharmacy investigators find common deficiencies which will also be discussed.
 
 
Pharmacist Learning Objectives
  • Differentiate between proposed and current regulations
  • Describe the common deficiencies found by investigators during pharmacy compliance inspections
  • Summarize new Board policies
Pharmacy Technician Learning Objectives
  • Differentiate between proposed and current regulations
  • Describe the common deficiencies found by investigators during pharmacy compliance inspections
  • Summarize new Board policies
 
Faculty
Edmond J. TaglieriMSM, RPh, NHA
PSUD Supervisor for Massachusetts Board of Pharmacy
 
ACPE UAN
0280-0000-18-023-L03-P (Knowledge-Based)
0280-0000-18-023-L03-T (Knowledge-Based)
 
Credits
1
 
Handouts
 
Supported By
American Health Resources, LLC.
 
 
 
 
Requirements for CE Credit
  • Participant Requirement and Statement of Credit: To receive credit, participants must fully attend each session (no partial credit will be awarded), pass in a completed attendance verification form, and using the access code provided, complete the online evaluation for each session attended. Attendance will be verified. All participants will have the opportunity to evaluate the educational sessions and presenters as well as the ability to identify their
  • Pharmacists and Pharmacy Technicians: CE credit will be automatically uploaded to CPE Monitor upon completion of the evaluation and posted to the participant’s NABP account within 72 hours where an official certificate of credit can be printed. Evaluations must be completed within 60 days of program date to receive credit.
  • Statement of Disclosure: Disclosure will be made on the day of the program regarding any interest or affiliation a speaker may have with a supporting organization.
  • Refund Policy: A full refund will be provided only if a written request is received by American Health Resources, LLC at least 48 hours prior to the program or if the program is cancelled. American Health Resources, LLC reserves the right to change the presenters, topics or seminar schedules.
 
Only Certificates of Credit issued from CPE Monitor are valid in the US.
CPE Monitor will not accept credits after 60 days from the session date.
 
Supported By:
American Health Resources, LLC.
 
Registration closes on 5/9/2018 at 11:00 PM
 

CONTINUING EDUCATION

843 488 5550 Office

843 488 5554 Fax

info@ahrevents.com Email

www.ahrevents.com Web

341 Wellness Drive, Myrtle Beach, SC 29579 Address

©2015 PharmCon, lnc. All Rights Reserved | Terms & Conditions | Privacy PolicyAmerican Health Resources, LLC a subsidiary of PharmCon, Inc.
Developed By: ITB, Inc.